{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-054273","form_type":"8-K","ticker":"FEMY","cik":"0001339005","company_name":"FEMASYS INC","filed_at":"2023-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.700477+00:00","generated_at":"2026-06-07T22:34:54.050242+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Femasys appoints Joshua Silverman to board in connection with private placement","bullets":["Joshua Silverman appointed director effective Nov 21, 2023, nominated by PharmaCyte Biotech under board nomination right.","Silverman serves as interim CEO, President and Director of PharmaCyte Biotech.","He is independent director under Nasdaq rules and will serve on Nominating Committee.","Term as Class II director until annual meeting following Dec 31, 2026; entitled to standard director compensation and indemnification.","Appointment follows previously announced private placement of convertible notes and warrants closed Nov 21, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-054273","json":"https://secwatch.observer/filing/0001140361-23-054273.json","markdown":"https://secwatch.observer/filing/0001140361-23-054273.md","text":"https://secwatch.observer/filing/0001140361-23-054273.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1339005/000114036123054273/0001140361-23-054273-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1339005/000114036123054273/ef20015127_form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T22:34:54.050242+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"98183a42ac","claim":"Joshua Silverman was appointed as director at FEMASYS INC.","evidence_excerpt":"the Board of Directors (the “Board”) of Femasys Inc. (the “Company”) appointed Joshua Silverman as director of the Company effective November 21, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036123054273/0001140361-23-054273-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}